Tirzepatide Immunogenicity on Pharmacokinetics, Efficacy, and Safety: Analysis of Data From Phase 3 Studies.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Tirzepatide Immunogenicity on Pharmacokinetics, Efficacy, and Safety: Analysis of Data From Phase 3 Studies.
- Published In:
- The Journal of clinical endocrinology and metabolism, 109(2), 361-369 (2024)
- Authors:
- Mullins, Garrett R, Hodsdon, Michael E, Li, Ying Grace, Anglin, Greg, Urva, Shweta, Schneck, Karen, Bardos, Jennifer N, Martins, Ricardo Fonseca, Brown, Katelyn, Calderon, Boris
- Database ID:
- RPEP-08913
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08913APA
Mullins, Garrett R; Hodsdon, Michael E; Li, Ying Grace; Anglin, Greg; Urva, Shweta; Schneck, Karen; Bardos, Jennifer N; Martins, Ricardo Fonseca; Brown, Katelyn; Calderon, Boris. (2024). Tirzepatide Immunogenicity on Pharmacokinetics, Efficacy, and Safety: Analysis of Data From Phase 3 Studies.. The Journal of clinical endocrinology and metabolism, 109(2), 361-369. https://doi.org/10.1210/clinem/dgad532
MLA
Mullins, Garrett R, et al. "Tirzepatide Immunogenicity on Pharmacokinetics, Efficacy, and Safety: Analysis of Data From Phase 3 Studies.." The Journal of clinical endocrinology and metabolism, 2024. https://doi.org/10.1210/clinem/dgad532
RethinkPeptides
RethinkPeptides Research Database. "Tirzepatide Immunogenicity on Pharmacokinetics, Efficacy, an..." RPEP-08913. Retrieved from https://rethinkpeptides.com/research/mullins-2024-tirzepatide-immunogenicity-on-pharmacokinetics
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.